Not Signed In -
Capecitabine |
Xeloda |
Capecitabine Systematic (IUPAC) name pentyl[1-(3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl)- 5-fluoro-2-oxo-1H-pyrimidin- 4-yl]aminomethanoate Identifiers CAS number 154361-50-9 ATC code L01BC06 PubChem 60953 DrugBank APRD00203 Chemical data Formula C15H22FN3O6 Mol. weight 359.35 g/mol Pharmacokinetic data Bioavailability Extensive Protein binding < 60% Metabolism Tissue metabolism to fluorouracil (active metabolite); hepatic metabolism to inactive me ...
Wikipedia - [full article]
Capecitabine Clinical Trials
- Capecitabine in Combination with Oxaliplatin (XELOX) vs. Fluorouracil/Leucovorin as Adjuvant Therapy for Patients who have Undergone Surgery for Colon Carcinoma
ClinicalTrials.gov Identifier: NCT00069121 - Active, not recruiting
Colorectal Cancer
- TBP Study with Capecitabine Plus Minus Trastuzumab
ClinicalTrials.gov Identifier: NCT00148876 - Active, not recruiting
Breast Cancer
- A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00435409 - Recruiting
Breast Neoplasms
- Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotnib Followed of Capecitabine
ClinicalTrials.gov Identifier: NCT00440167 - Recruiting
Advanced; Pancreatic Cancer
- This is a Study of Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00546364 - Recruiting
Breast Neoplasms
- Aroplatin and Capecitabine in Patients with Advanced Colorectal Cancer Resistant to Standard Therapies
ClinicalTrials.gov Identifier: NCT00081536 - Active, not recruiting
Colorectal Neoplasms
- Novel Epothilone plus Capecitabine versus Capecitabine Alone in Patients with Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00080301 - Active, not recruiting
Breast Cancer; Metastases
- Combination of Capecitabine (Xeloda) and Bevacizumab (Avastin) for Treatment of Metastatic Breast Cancer in Patients Who Are HER2 Negative (Do Not Have Too Many Copies of the HER2 Gene) Followed by Chemotherapy Combined with Bevacizumab If Disease Progres
ClinicalTrials.gov Identifier: NCT00121836 - Active, not recruiting
Breast Cancer
- Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00151047 - Active, not recruiting
Prostate Cancer
- SB-715992 in Combination with Capecitabine in Patients with Solid Tumors
ClinicalTrials.gov Identifier: NCT00119171 - Active, not recruiting
Tumors
- Phase IV Capecitabine and Docetaxel Combination for Neoadjuvant Treatment of Patients with Recently Diagnosed Breast Cancer and with Trastuzumab for Patients That Are Positive for Her2-Neu.
ClinicalTrials.gov Identifier: NCT00127933 - Active, not recruiting
Breast Cancer
- Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer
ClinicalTrials.gov Identifier: NCT00216086 - Recruiting
Rectal Cancer
- Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00415285 - Recruiting
Breast Neoplasms
- A 2x2 (4-way) study of capecitabine in combo w/ oxaliplatin (XELOX) w/ or w/out bevacizumab vs. fluorouracil/leucovorin w/ oxaliplatin (FOLFOX-4) w/ or w/out bevacizumab as first-line treatment for pts w/ metastatic colorectal cancer
ClinicalTrials.gov Identifier: NCT00069095 - Active, not recruiting
Metastatic Colorectal Cancer
- Epothilone (ixabepilone) plus Capecitabine versus Capecitabine Alone in Patients with Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00082433 - Active, not recruiting
Cancer; Breast Cancer
- Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine
ClinicalTrials.gov Identifier: NCT00156312 - Active, not recruiting
Breast Cancer
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Metastatic or Inoperable Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (Cancer)
ClinicalTrials.gov Identifier: NCT00084617 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00040859 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement
ClinicalTrials.gov Identifier: NCT00003902 - Active, not recruiting
stage IV breast cancer
- Maintenance Treatment with Capecitabine Vs. Observation in ER, PgR and HER2 Negative Breast Cancer Patients.
ClinicalTrials.gov Identifier: NCT00130533 - Recruiting
Breast cancer.
- A study of capecitabine in combo w/ XELOX vs fluorouracil/leucovorin w/ oxaliplatin (FOLFOX4) as treatment for pts w/ metastatic colorectal cancer, who have received prior treatment w/ CPT-11 in combo w/ fluorouracil/leucovorin
ClinicalTrials.gov Identifier: NCT00069108 - Active, not recruiting
Colorectal Cancer; Metastases
- Gemcitabine and Capecitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Gallbladder Cancer or Cholangiocarcinoma
ClinicalTrials.gov Identifier: NCT00033540 - Active, not recruiting
extrahepatic bile duct cancer; Gallbladder Cancer
- Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00049660 - Active, not recruiting
stage IV breast cancer
- LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00052273 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00077363 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00006023 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Study of Sunitinib in Combination With Cisplatin/Capecitabine or Oxaliplatin/Capecitabine in Patients With Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00555620 - Not yet recruiting
Cancer of the Stomach
- A Study Comparing Two Different Treatment Schedules of Intermittent Capecitabine and Oxaliplatin Combined with Bevacizumab As First-Line Treatment (Previously Not Been Treated) for Patients with Metastatic Colorectal Cancer.
ClinicalTrials.gov Identifier: NCT00118755 - Recruiting
Colorectal Cancer
- Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00153907 - Active, not recruiting
Breast Cancer
- Oxaliplatin and Capecitabine Versus Follow-Up After Resection of Colorectal Liver Metastases
ClinicalTrials.gov Identifier: NCT00156975 - Active, not recruiting
Colorectal Neoplasms; Liver Metastases
- Suberoylanilide Hydroxamic Acid and Capecitabine in Treating Patients with Metastatic Or Unresectable Solid Tumors
ClinicalTrials.gov Identifier: NCT00121277 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00084734 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
ClinicalTrials.gov Identifier: NCT00074321 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00083148 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors
ClinicalTrials.gov Identifier: NCT00084643 - Active, not recruiting
adult solid tumor; Colon Cancer; Rectal Cancer
- Capecitabine Compared With Fluorouracil Plus Leucovorin in Treating Patients Who Have Undergone Surgery for Stage III Colon Cancer
ClinicalTrials.gov Identifier: NCT00009737 - Active, not recruiting
stage III colon cancer
- Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00010023 - Active, not recruiting
Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer
- Gemcitabine, Docetaxel, and Capecitabine in Treating Patients with Cancer of Unknown Primary Origin
ClinicalTrials.gov Identifier: NCT00119314 - Active, not recruiting
newly diagnosed carcinoma of unknown primary; recurrent carcinoma of unknown primary
- Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00107393 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Tarceva and Capecitabine for Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00125021 - Active, not recruiting
Pancreatic Cancer; Neoplasm Metastasis
- Paclitaxel and Capecitabine in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00005649 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00042965 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
ClinicalTrials.gov Identifier: NCT00039442 - Active, not recruiting
recurrent cervical cancer; cervical adenocarcinoma; cervical adenosquamous cell carcinoma
- Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00087152 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00049244 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00031876 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients with Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00159432 - Recruiting
Colorectal Cancer
- The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (Study P04445)
ClinicalTrials.gov Identifier: NCT00266799 - Recruiting
Breast Cancer
- GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00068588 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision
ClinicalTrials.gov Identifier: NCT00174616 - Active, not recruiting
Rectal Neoplasms
- Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.
ClinicalTrials.gov Identifier: NCT00159471 - Recruiting
Pancreatic Cancer
- Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00107276 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers.
ClinicalTrials.gov Identifier: NCT00177255 - Active, not recruiting
Cancer
- Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov Identifier: NCT00073905 - Active, not recruiting
adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer; Pain
- Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00088998 - Active, not recruiting
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
- Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00265733 - Active, not recruiting
Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
- Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006108 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer
ClinicalTrials.gov Identifier: NCT00084591 - Active, not recruiting
stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
- Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
ClinicalTrials.gov Identifier: NCT00249977 - Active, not recruiting
Solid Tumors; Cancer
- Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater
ClinicalTrials.gov Identifier: NCT00354887 - Active, not recruiting
Gastrointestinal Cancer
- Capecitabine in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00004183 - Active, not recruiting
recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma; sarcomatous mesothelioma; ...
- Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
ClinicalTrials.gov Identifier: NCT00058318 - Active, not recruiting
Stage IV Renal Cell Cancer; stage III renal cell cancer
- A Study of Two Different Dosing Regimens of Capecitabine in Combo with Intravenous Docetaxel (Q3W) in Patients with Locally Advanced and/or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00077857 - Recruiting
Metastatic breast cancer; Metastatic Colorectal Cancer
- Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00104689 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
- Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Salivary Gland Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00101075 - Active, not recruiting
high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer
- Urokinase-plasminogen activator (uPA) inhibitor WX-UK1 in combination with Capecitabine in Advanced Malignancies
ClinicalTrials.gov Identifier: NCT00083525 - Recruiting
Advanced malignancies
- Capecitabine in Treating Older Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
ClinicalTrials.gov Identifier: NCT00049335 - Active, not recruiting
recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
- Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00100815 - Active, not recruiting
adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00026442 - Active, not recruiting
stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Irinotecan and Capecitabine in Treating Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00003867 - Active, not recruiting
Pancreatic Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer; Colon Cancer; Rectal Cancer; Breast Cancer
- Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00114179 - Active, not recruiting
adenocarcinoma of the pancreas; stage III pancreatic cancer; stage II pancreatic cancer
- Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
ClinicalTrials.gov Identifier: NCT00081224 - Active, not recruiting
adenocarcinoma of the rectum; stage II rectal cancer; stage III rectal cancer
- An Open-Label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine
ClinicalTrials.gov Identifier: NCT00165880 - Active, not recruiting
Metastatic Breast Cancer
- Capecitabine in Treating Patients With Locally Recurrent or Metastatic Nasopharygeal Cancer
ClinicalTrials.gov Identifier: NCT00095901 - Active, not recruiting
recurrent squamous cell carcinoma of the nasopharynx; stage IV squamous cell carcinoma of the nasopharynx; ...
- Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00171587 - Active, not recruiting
Tumors; Neoplasm Metastasis
- Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00291486 - Active, not recruiting
Colorectal Neoplasms
- Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer.
ClinicalTrials.gov Identifier: NCT00177307 - Active, not recruiting
Cancer
- Capecitabine and Gemcitabine in Patients with Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00159445 - Recruiting
Colorectal Cancer; Colon Cancer
- Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00087334 - Active, not recruiting
recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
- Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder
ClinicalTrials.gov Identifier: NCT00084942 - Active, not recruiting
cholangiocarcinoma of the gallbladder; recurrent gallbladder cancer; unresectable gallbladder cancer; ...
- Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
ClinicalTrials.gov Identifier: NCT00320918 - Active, not recruiting
Cholangiocarcinoma
- Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer
ClinicalTrials.gov Identifier: NCT00506623 - Active, not recruiting
Rectal Neoplasm; Neoadjuvant Therapy
- Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00194727 - Active, not recruiting
Breast Neoplasm
- Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
ClinicalTrials.gov Identifier: NCT00354523 - Active, not recruiting
Solid Tumor; Thyroid Cancer
- Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
ClinicalTrials.gov Identifier: NCT00314353 - Active, not recruiting
Colorectal Neoplasms
- Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00054457 - Active, not recruiting
adenocarcinoma of the stomach; Adenocarcinoma of the Esophagus; stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; ...
- A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer.
ClinicalTrials.gov Identifier: NCT00122291 - Recruiting
Rectal Cancer; Transmural Rectal Wall Invasion; Nodal Metastasis
- Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00062426 - Active, not recruiting
adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; ...
- Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00070213 - Recruiting
Colon Cancer; Quality of Life; Rectal Cancer
- Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00030732 - Active, not recruiting
stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Oxaliplatin and Capecitabine With or Without Hepatic Arterial Infusion of Floxuridine in Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases From Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00268463 - Active, not recruiting
Liver Metastases; Stage IV Colon Cancer; Stage IV Rectal Cancer; Adenocarcinoma of the Colon; Adenocarcinoma of the Rectum
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00217711 - Active, not recruiting
Colorectal Cancer
- Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery
ClinicalTrials.gov Identifier: NCT00251329 - Active, not recruiting
Breast Cancer
- Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
ClinicalTrials.gov Identifier: NCT00220168 - Active, not recruiting
Upper Gastrointestinal Tumours
- A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
ClinicalTrials.gov Identifier: NCT00246090 - Active, not recruiting
Breast Cancer
- Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00227734 - Active, not recruiting
Colorectal Cancer
- A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.
ClinicalTrials.gov Identifier: NCT00439426 - Active, not recruiting
Nasopharyngeal Cancer
- Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00303745 - Active, not recruiting
Colorectal Cancer
- Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
ClinicalTrials.gov Identifier: NCT00215501 - Active, not recruiting
Solid Tumor
- Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00215982 - Active, not recruiting
Metastatic Colorectal Cancer
Resources
- Capecitabine (Drug Digest)
- Xeloda (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
